Joel Greenblatt’s Terns Pharmaceuticals TERN Stock Holding History

Joel Greenblatt’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,497	Closed	-$870K	–	1887
2026 Q1	$870K	Buy	16,497 +5,021	+44%	+$206K	﹤0.01%	1352
2025 Q4	$464K	Buy	+11,476	New	+$265K	﹤0.01%	1463

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Joel Greenblatt's TERN Position: Q2 2026 in Review

Joel Greenblatt sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 16,497 shares — an estimated $870K sold.

Joel Greenblatt first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $870K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Joel Greenblatt reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Joel Greenblatt sold 16,497 Terns Pharmaceuticals shares in Q2 2026, an estimated $870K.
Joel Greenblatt first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Joel Greenblatt's Terns Pharmaceuticals position peaked at $870K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.